Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Targeting EGFR may help reduce hair loss from chemotherapy.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

A new method using Y-27632 improves the growth and quality of human hair follicle stem cells for tissue engineering and therapy.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

The HIF-2α/ARNT complex is important for hair follicle development by controlling cell growth.

The study created a new method to test drugs that affect hormone processing in skin.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

New compounds show promise as nonsteroidal treatments for hair loss.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.